Ultromics

📍 Oxford, United Kingdom🗓 Founded 2017👥 79 employees💰 Last funded Jul 2025
Hospitals and Health Care🌐 ultromics.com
Website LinkedIn
Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound. Our technology empowers clinicians to make precise, efficient, and accurate assessments, drawing from the largest known heart disease dataset in echocardiography. We target challenging cardiac diseases, starting with HFpEF, to support timely diagnosis and early intervention. In collaboration with the Mayo Clinic, Johnson & Johnson, and Pfizer, we are continuously developing innovative diagnostic tools aimed at halting the progression of heart failure. Learn more: https://www.ultromics.com/. Follow Ultromics on social media for the latest news, X: https://x.com/ultromics, LinkedIn: https://www.linkedin.com/company/ultromics/.
7
Total investors
2
Early stage
3
Mid stage
2
Late stage
2017
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
5
United States
2
Investor activity2017–2025 · investors recorded per year
20172202012021220252
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Ultromics?
Ultromics has 7 investors on record on gritt.io, including 2 early-stage backers, 3 mid-stage and 2 late-stage investors.
When did Ultromics last raise funding?
The most recent investment in Ultromics recorded on gritt.io was in July 2025.
When was Ultromics founded?
Ultromics was founded in 2017.
What industry is Ultromics in?
Ultromics operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Ultromics based?
Ultromics is headquartered in Oxford, United Kingdom.